Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 280 entries
Sorted by: Best Match Show Resources per page
A pool of peptides extracted from wheat bud chromatin inhibits tumor cell growth by causing defective DNA synthesis.

Cell division

Mancinelli L, Secca T, De Angelis PM, Mancini F, Marchesini M, Marinelli C, Barberini L, Grignani F.
PMID: 23915323
Cell Div. 2013 Aug 06;8:11. doi: 10.1186/1747-1028-8-11. eCollection 2013.

BACKGROUND: We previously reported that a pool of low molecular weight peptides can be extracted by alkali treatment of DNA preparations obtained from prokaryotic and eukaryotic cells after intensive deproteinization. This class of peptides, isolated from wheat bud chromatin,...

Cite
Mancinelli L, Secca T, De Angelis PM, et al. A pool of peptides extracted from wheat bud chromatin inhibits tumor cell growth by causing defective DNA synthesis. Cell Div. 2013;8:11doi: 10.1186/1747-1028-8-11.
Mancinelli, L., Secca, T., De Angelis, P. M., Mancini, F., Marchesini, M., Marinelli, C., Barberini, L., & Grignani, F. (2013). A pool of peptides extracted from wheat bud chromatin inhibits tumor cell growth by causing defective DNA synthesis. Cell division, 811. https://doi.org/10.1186/1747-1028-8-11
Mancinelli, Loretta, et al. "A pool of peptides extracted from wheat bud chromatin inhibits tumor cell growth by causing defective DNA synthesis." Cell division vol. 8 (2013): 11. doi: https://doi.org/10.1186/1747-1028-8-11
Mancinelli L, Secca T, De Angelis PM, Mancini F, Marchesini M, Marinelli C, Barberini L, Grignani F. A pool of peptides extracted from wheat bud chromatin inhibits tumor cell growth by causing defective DNA synthesis. Cell Div. 2013 Aug 06;8:11. doi: 10.1186/1747-1028-8-11. eCollection 2013. PMID: 23915323; PMCID: PMC3750333.
Copy Download .nbib Format: NLM
Occurrence of Fatal and Nonfatal Adverse Outcomes after Heart Transplantation in Patients with Pretransplant Noncytotoxic HLA Antibodies.

Journal of transplantation

Potena L, Bontadini A, Iannelli S, Fruet F, Leone O, Barberini F, Borgese L, Manfredini V, Masetti M, Magnani G, Fallani F, Grigioni F, Branzi A.
PMID: 23984043
J Transplant. 2013;2013:519680. doi: 10.1155/2013/519680. Epub 2013 Jul 29.

HLA antibodies (HLA ab) in transplant candidates have been associated with poor outcome. However, clinical relevance of noncytotoxic antibodies after heart transplant (HT) is controversial. By using a Luminex-based HLA screening, we retested pretransplant sera from HT recipients testing...

Cite
Potena L, Bontadini A, Iannelli S, et al. Occurrence of Fatal and Nonfatal Adverse Outcomes after Heart Transplantation in Patients with Pretransplant Noncytotoxic HLA Antibodies. J Transplant. 2013;2013:519680doi: 10.1155/2013/519680.
Potena, L., Bontadini, A., Iannelli, S., Fruet, F., Leone, O., Barberini, F., Borgese, L., Manfredini, V., Masetti, M., Magnani, G., Fallani, F., Grigioni, F., & Branzi, A. (2013). Occurrence of Fatal and Nonfatal Adverse Outcomes after Heart Transplantation in Patients with Pretransplant Noncytotoxic HLA Antibodies. Journal of transplantation, 2013519680. https://doi.org/10.1155/2013/519680
Potena, Luciano, et al. "Occurrence of Fatal and Nonfatal Adverse Outcomes after Heart Transplantation in Patients with Pretransplant Noncytotoxic HLA Antibodies." Journal of transplantation vol. 2013 (2013): 519680. doi: https://doi.org/10.1155/2013/519680
Potena L, Bontadini A, Iannelli S, Fruet F, Leone O, Barberini F, Borgese L, Manfredini V, Masetti M, Magnani G, Fallani F, Grigioni F, Branzi A. Occurrence of Fatal and Nonfatal Adverse Outcomes after Heart Transplantation in Patients with Pretransplant Noncytotoxic HLA Antibodies. J Transplant. 2013;2013:519680. doi: 10.1155/2013/519680. Epub 2013 Jul 29. PMID: 23984043; PMCID: PMC3745955.
Copy Download .nbib Format: NLM
Confinement-deconfinement transition in three-dimensional QED.

Physical review. D, Particles and fields

Grignani G, Semenoff G, Sodano P.
PMID: 10020003
Phys Rev D Part Fields. 1996 Jun 15;53(12):7157-7161. doi: 10.1103/physrevd.53.7157.

No abstract available.

Cite
Grignani G, Semenoff G, Sodano P. Confinement-deconfinement transition in three-dimensional QED. Phys Rev D Part Fields. 1996;53(12):7157-7161doi: 10.1103/physrevd.53.7157.
Grignani, G., Semenoff, G., & Sodano, P. (1996). Confinement-deconfinement transition in three-dimensional QED. Physical review. D, Particles and fields, 53(12), 7157-7161. https://doi.org/10.1103/physrevd.53.7157
Grignani, et al. "Confinement-deconfinement transition in three-dimensional QED." Physical review. D, Particles and fields vol. 53,12 (1996): 7157-7161. doi: https://doi.org/10.1103/physrevd.53.7157
Grignani G, Semenoff G, Sodano P. Confinement-deconfinement transition in three-dimensional QED. Phys Rev D Part Fields. 1996 Jun 15;53(12):7157-7161. doi: 10.1103/physrevd.53.7157. PMID: 10020003.
Copy Download .nbib Format: NLM
Scattering of low-energy fermions by a Chern-Simons vortex.

Physical review. D, Particles and fields

Grignani G, Nardelli G.
PMID: 10012827
Phys Rev D Part Fields. 1990 Dec 15;42(12):4145-4158. doi: 10.1103/physrevd.42.4145.

No abstract available.

Cite
Grignani G, Nardelli G. Scattering of low-energy fermions by a Chern-Simons vortex. Phys Rev D Part Fields. 1990;42(12):4145-4158doi: 10.1103/physrevd.42.4145.
Grignani, G., & Nardelli, G. (1990). Scattering of low-energy fermions by a Chern-Simons vortex. Physical review. D, Particles and fields, 42(12), 4145-4158. https://doi.org/10.1103/physrevd.42.4145
Grignani, and Nardelli. "Scattering of low-energy fermions by a Chern-Simons vortex." Physical review. D, Particles and fields vol. 42,12 (1990): 4145-4158. doi: https://doi.org/10.1103/physrevd.42.4145
Grignani G, Nardelli G. Scattering of low-energy fermions by a Chern-Simons vortex. Phys Rev D Part Fields. 1990 Dec 15;42(12):4145-4158. doi: 10.1103/physrevd.42.4145. PMID: 10012827.
Copy Download .nbib Format: NLM
Supersymmetry anomaly in ten dimensions.

Physical review. D, Particles and fields

Grignani G.
PMID: 9959336
Phys Rev D Part Fields. 1988 Sep 15;38(6):1859-1862. doi: 10.1103/physrevd.38.1859.

No abstract available.

Cite
Grignani G. Supersymmetry anomaly in ten dimensions. Phys Rev D Part Fields. 1988;38(6):1859-1862doi: 10.1103/physrevd.38.1859.
Grignani, G. (1988). Supersymmetry anomaly in ten dimensions. Physical review. D, Particles and fields, 38(6), 1859-1862. https://doi.org/10.1103/physrevd.38.1859
Grignani. "Supersymmetry anomaly in ten dimensions." Physical review. D, Particles and fields vol. 38,6 (1988): 1859-1862. doi: https://doi.org/10.1103/physrevd.38.1859
Grignani G. Supersymmetry anomaly in ten dimensions. Phys Rev D Part Fields. 1988 Sep 15;38(6):1859-1862. doi: 10.1103/physrevd.38.1859. PMID: 9959336.
Copy Download .nbib Format: NLM
Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung Cancer.

Journal of clinical medicine

Ulivi P, Petracci E, Marisi G, Baglivo S, Chiari R, Billi M, Canale M, Pasini L, Racanicchi S, Vagheggini A, Delmonte A, Mariotti M, Ludovini V, Bonafè M, Crinò L, Grignani F.
PMID: 30678026
J Clin Med. 2019 Jan 23;8(2). doi: 10.3390/jcm8020131.

Non-small cell lung cancer (NSCLC) is the primary cause of cancer-related death worldwide, with a low 5-year survival rate even in fully resected early-stage disease. Novel biomarkers to identify patients at higher risk of relapse are needed. We studied...

Cite
Ulivi P, Petracci E, Marisi G, et al. Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung Cancer. J Clin Med. 2019;8(2)doi: 10.3390/jcm8020131.
Ulivi, P., Petracci, E., Marisi, G., Baglivo, S., Chiari, R., Billi, M., Canale, M., Pasini, L., Racanicchi, S., Vagheggini, A., Delmonte, A., Mariotti, M., Ludovini, V., Bonafè, M., Crinò, L., & Grignani, F. (2019). Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung Cancer. Journal of clinical medicine, 8(2), . https://doi.org/10.3390/jcm8020131
Ulivi, Paola, et al. "Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung Cancer." Journal of clinical medicine vol. 8,2 (2019). doi: https://doi.org/10.3390/jcm8020131
Ulivi P, Petracci E, Marisi G, Baglivo S, Chiari R, Billi M, Canale M, Pasini L, Racanicchi S, Vagheggini A, Delmonte A, Mariotti M, Ludovini V, Bonafè M, Crinò L, Grignani F. Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung Cancer. J Clin Med. 2019 Jan 23;8(2). doi: 10.3390/jcm8020131. PMID: 30678026; PMCID: PMC6407000.
Copy Download .nbib Format: NLM
Publisher Correction: Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer.

Nature genetics

Chen J, Guccini I, Di Mitri D, Brina D, Revandkar A, Sarti M, Pasquini E, Alajati A, Pinton S, Losa M, Civenni G, Catapano CV, Sgrignani J, Cavalli A, D'Antuono R, Asara JM, Morandi A, Chiarugi P, Crotti S, Agostini M, Montopoli M, Masgras I, Rasola A, Garcia-Escudero R, Delaleu N, Rinaldi A, Bertoni F, de Bono J, Carracedo A, Alimonti A.
PMID: 30089860
Nat Genet. 2018 Sep;50(9):1343. doi: 10.1038/s41588-018-0181-1.

In the HTML version of this article initially published, the name of author Diletta Di Mitri was miscoded in the XML such that Di was included as part of the given name instead of the family name. The error...

Cite
Chen J, Guccini I, Di Mitri D, et al. Publisher Correction: Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer. Nat Genet. 2018;50(9):1343doi: 10.1038/s41588-018-0181-1.
Chen, J., Guccini, I., Di Mitri, D., Brina, D., Revandkar, A., Sarti, M., Pasquini, E., Alajati, A., Pinton, S., Losa, M., Civenni, G., Catapano, C. V., Sgrignani, J., Cavalli, A., D'Antuono, R., Asara, J. M., Morandi, A., Chiarugi, P., Crotti, S., Agostini, M., Montopoli, M., Masgras, I., Rasola, A., Garcia-Escudero, R., Delaleu, N., Rinaldi, A., Bertoni, F., de Bono, J., Carracedo, A., & Alimonti, A. (2018). Publisher Correction: Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer. Nature genetics, 50(9), 1343. https://doi.org/10.1038/s41588-018-0181-1
Chen, Jingjing, et al. "Publisher Correction: Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer." Nature genetics vol. 50,9 (2018): 1343. doi: https://doi.org/10.1038/s41588-018-0181-1
Chen J, Guccini I, Di Mitri D, Brina D, Revandkar A, Sarti M, Pasquini E, Alajati A, Pinton S, Losa M, Civenni G, Catapano CV, Sgrignani J, Cavalli A, D'Antuono R, Asara JM, Morandi A, Chiarugi P, Crotti S, Agostini M, Montopoli M, Masgras I, Rasola A, Garcia-Escudero R, Delaleu N, Rinaldi A, Bertoni F, de Bono J, Carracedo A, Alimonti A. Publisher Correction: Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer. Nat Genet. 2018 Sep;50(9):1343. doi: 10.1038/s41588-018-0181-1. PMID: 30089860.
Copy Download .nbib Format: NLM
Towards a formalin-free hospital. Levels of 15-F2t-isoprostane and malondialdehyde to monitor exposure to formaldehyde in nurses from operating theatres.

Toxicology research

Bellisario V, Mengozzi G, Grignani E, Bugiani M, Sapino A, Bussolati G, Bono R.
PMID: 30090418
Toxicol Res (Camb). 2016 Apr 26;5(4):1122-1129. doi: 10.1039/c6tx00068a. eCollection 2016 Jul 01.

No abstract available.

Cite
Bellisario V, Mengozzi G, Grignani E, et al. Towards a formalin-free hospital. Levels of 15-F2t-isoprostane and malondialdehyde to monitor exposure to formaldehyde in nurses from operating theatres. Toxicol Res (Camb). 2016;5(4):1122-1129doi: 10.1039/c6tx00068a.
Bellisario, V., Mengozzi, G., Grignani, E., Bugiani, M., Sapino, A., Bussolati, G., & Bono, R. (2016). Towards a formalin-free hospital. Levels of 15-F2t-isoprostane and malondialdehyde to monitor exposure to formaldehyde in nurses from operating theatres. Toxicology research, 5(4), 1122-1129. https://doi.org/10.1039/c6tx00068a
Bellisario, Valeria, et al. "Towards a formalin-free hospital. Levels of 15-F2t-isoprostane and malondialdehyde to monitor exposure to formaldehyde in nurses from operating theatres." Toxicology research vol. 5,4 (2016): 1122-1129. doi: https://doi.org/10.1039/c6tx00068a
Bellisario V, Mengozzi G, Grignani E, Bugiani M, Sapino A, Bussolati G, Bono R. Towards a formalin-free hospital. Levels of 15-F2t-isoprostane and malondialdehyde to monitor exposure to formaldehyde in nurses from operating theatres. Toxicol Res (Camb). 2016 Apr 26;5(4):1122-1129. doi: 10.1039/c6tx00068a. eCollection 2016 Jul 01. PMID: 30090418; PMCID: PMC6060729.
Copy Download .nbib Format: NLM
Correction to: Thrombus aspiration in hyperglycemic ST-elevation myocardial infarction (STEMI) patients: clinical outcomes at 1-year follow-up.

Cardiovascular diabetology

Sardu C, Barbieri M, Balestrieri ML, Siniscalchi M, Paolisso P, Calabrò P, Minicucci F, Signoriello G, Portoghese M, Mone P, D'Andrea D, Gragnano F, Bellis A, Mauro C, Paolisso G, Rizzo MR, Marfella R.
PMID: 30591048
Cardiovasc Diabetol. 2018 Dec 27;17(1):159. doi: 10.1186/s12933-018-0804-y.

Following publication of the original article [1], the authors reported an error in Acknowledgment section. The last sentence should read as "All authors have read and approval the submission to Cardiovascular Diabetology.

Cite
Sardu C, Barbieri M, Balestrieri ML, et al. Correction to: Thrombus aspiration in hyperglycemic ST-elevation myocardial infarction (STEMI) patients: clinical outcomes at 1-year follow-up. Cardiovasc Diabetol. 2018;17(1):159doi: 10.1186/s12933-018-0804-y.
Sardu, C., Barbieri, M., Balestrieri, M. L., Siniscalchi, M., Paolisso, P., Calabrò, P., Minicucci, F., Signoriello, G., Portoghese, M., Mone, P., D'Andrea, D., Gragnano, F., Bellis, A., Mauro, C., Paolisso, G., Rizzo, M. R., & Marfella, R. (2018). Correction to: Thrombus aspiration in hyperglycemic ST-elevation myocardial infarction (STEMI) patients: clinical outcomes at 1-year follow-up. Cardiovascular diabetology, 17(1), 159. https://doi.org/10.1186/s12933-018-0804-y
Sardu, Celestino, et al. "Correction to: Thrombus aspiration in hyperglycemic ST-elevation myocardial infarction (STEMI) patients: clinical outcomes at 1-year follow-up." Cardiovascular diabetology vol. 17,1 (2018): 159. doi: https://doi.org/10.1186/s12933-018-0804-y
Sardu C, Barbieri M, Balestrieri ML, Siniscalchi M, Paolisso P, Calabrò P, Minicucci F, Signoriello G, Portoghese M, Mone P, D'Andrea D, Gragnano F, Bellis A, Mauro C, Paolisso G, Rizzo MR, Marfella R. Correction to: Thrombus aspiration in hyperglycemic ST-elevation myocardial infarction (STEMI) patients: clinical outcomes at 1-year follow-up. Cardiovasc Diabetol. 2018 Dec 27;17(1):159. doi: 10.1186/s12933-018-0804-y. PMID: 30591048; PMCID: PMC6307298.
Copy Download .nbib Format: NLM
How a Clinical Trial Unit can improve independent clinical research in rare tumors: the Italian Sarcoma Group experience.

Clinical sarcoma research

Marchesi E, Cagnazzo C, Quattrini I, Leopardi MP, Villa C, Grignani G, D'Ambrosio L, Stacchiotti S, Casali PG, Picci P.
PMID: 28261443
Clin Sarcoma Res. 2017 Feb 28;7:4. doi: 10.1186/s13569-017-0068-4. eCollection 2017.

BACKGROUND: The Italian Sarcoma Group (ISG) is a nonprofit group of professionals established in 1997 aimed to improve the quality of care and promote the independent research in sarcomas. The increased regulatory requirements, the chance to increase the number...

Cite
Marchesi E, Cagnazzo C, Quattrini I, et al. How a Clinical Trial Unit can improve independent clinical research in rare tumors: the Italian Sarcoma Group experience. Clin Sarcoma Res. 2017;7:4doi: 10.1186/s13569-017-0068-4.
Marchesi, E., Cagnazzo, C., Quattrini, I., Leopardi, M. P., Villa, C., Grignani, G., D'Ambrosio, L., Stacchiotti, S., Casali, P. G., & Picci, P. (2017). How a Clinical Trial Unit can improve independent clinical research in rare tumors: the Italian Sarcoma Group experience. Clinical sarcoma research, 74. https://doi.org/10.1186/s13569-017-0068-4
Marchesi, Emanuela, et al. "How a Clinical Trial Unit can improve independent clinical research in rare tumors: the Italian Sarcoma Group experience." Clinical sarcoma research vol. 7 (2017): 4. doi: https://doi.org/10.1186/s13569-017-0068-4
Marchesi E, Cagnazzo C, Quattrini I, Leopardi MP, Villa C, Grignani G, D'Ambrosio L, Stacchiotti S, Casali PG, Picci P. How a Clinical Trial Unit can improve independent clinical research in rare tumors: the Italian Sarcoma Group experience. Clin Sarcoma Res. 2017 Feb 28;7:4. doi: 10.1186/s13569-017-0068-4. eCollection 2017. PMID: 28261443; PMCID: PMC5329913.
Copy Download .nbib Format: NLM
Eicosapentaenoic acid induces DNA demethylation in carcinoma cells through a TET1-dependent mechanism.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Ceccarelli V, Valentini V, Ronchetti S, Cannarile L, Billi M, Riccardi C, Ottini L, Talesa VN, Grignani F, Vecchini A.
PMID: 29757674
FASEB J. 2018 May 14;fj201800245R. doi: 10.1096/fj.201800245R. Epub 2018 May 14.

In cancer cells, global genomic hypomethylation is found together with localized hypermethylation of CpG islands within the promoters and regulatory regions of silenced tumor suppressor genes. Demethylating agents may reverse hypermethylation, thus promoting gene re-expression. Unfortunately, demethylating strategies are...

Cite
Ceccarelli V, Valentini V, Ronchetti S, et al. Eicosapentaenoic acid induces DNA demethylation in carcinoma cells through a TET1-dependent mechanism. FASEB J. 2018;fj201800245Rdoi: 10.1096/fj.201800245R.
Ceccarelli, V., Valentini, V., Ronchetti, S., Cannarile, L., Billi, M., Riccardi, C., Ottini, L., Talesa, V. N., Grignani, F., & Vecchini, A. (2018). Eicosapentaenoic acid induces DNA demethylation in carcinoma cells through a TET1-dependent mechanism. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, fj201800245R. https://doi.org/10.1096/fj.201800245R
Ceccarelli, Veronica, et al. "Eicosapentaenoic acid induces DNA demethylation in carcinoma cells through a TET1-dependent mechanism." FASEB journal : official publication of the Federation of American Societies for Experimental Biology vol. (2018): fj201800245R. doi: https://doi.org/10.1096/fj.201800245R
Ceccarelli V, Valentini V, Ronchetti S, Cannarile L, Billi M, Riccardi C, Ottini L, Talesa VN, Grignani F, Vecchini A. Eicosapentaenoic acid induces DNA demethylation in carcinoma cells through a TET1-dependent mechanism. FASEB J. 2018 May 14;fj201800245R. doi: 10.1096/fj.201800245R. Epub 2018 May 14. PMID: 29757674.
Copy Download .nbib Format: NLM
Correction: Inherited variants in genes somatically mutated in thyroid cancer.

PloS one

Campo C, Köhler A, Figlioli G, Elisei R, Romei C, Cipollini M, Bambi F, Hemminki K, Gemignani F, Landi S, Försti A.
PMID: 30086163
PLoS One. 2018 Aug 07;13(8):e0202208. doi: 10.1371/journal.pone.0202208. eCollection 2018.

[This corrects the article DOI: 10.1371/journal.pone.0174995.].

Cite
Campo C, Köhler A, Figlioli G, et al. Correction: Inherited variants in genes somatically mutated in thyroid cancer. PLoS One. 2018;13(8):e0202208doi: 10.1371/journal.pone.0202208.
Campo, C., Köhler, A., Figlioli, G., Elisei, R., Romei, C., Cipollini, M., Bambi, F., Hemminki, K., Gemignani, F., Landi, S., & Försti, A. (2018). Correction: Inherited variants in genes somatically mutated in thyroid cancer. PloS one, 13(8), e0202208. https://doi.org/10.1371/journal.pone.0202208
Campo, Chiara, et al. "Correction: Inherited variants in genes somatically mutated in thyroid cancer." PloS one vol. 13,8 (2018): e0202208. doi: https://doi.org/10.1371/journal.pone.0202208
Campo C, Köhler A, Figlioli G, Elisei R, Romei C, Cipollini M, Bambi F, Hemminki K, Gemignani F, Landi S, Försti A. Correction: Inherited variants in genes somatically mutated in thyroid cancer. PLoS One. 2018 Aug 07;13(8):e0202208. doi: 10.1371/journal.pone.0202208. eCollection 2018. PMID: 30086163; PMCID: PMC6080776.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 280 entries